Gaja A, Franková H, Kocák I, Slapnicková J, Hejlová N
Masarykův onkologický ústav, Brno.
Vnitr Lek. 1999 Jul;45(7):409-13.
Interferons are commonly used, frequently already as a standard drug, in a relatively wide spectrum of indications in tumourous and non-tumourous diseases. The numerous undesirable therapeutic effects include also relatively frequent induction of autoimmune processes which, however, only rarely is associated with marked clinical manifestations. The author presents an account on two patients from their own clinical practice treated with interferon alpha who developed complications which in the author's opinion may be associated with autoimmunity (a patient with thrombocytopenia responding well to immunosuppressive treatment, originally treated on a chi ount of renal carcinoma, and a female patient with pulmonary sarcoidosis treated for essential thrombocythemia). The authors present also a brief review of the literature on autoimmunity induced by interferon.
干扰素在肿瘤性疾病和非肿瘤性疾病的相对广泛适应症中常用,常常已经作为标准药物使用。众多不良治疗效果还包括相对频繁地诱发自身免疫过程,然而,这种情况仅很少与明显的临床表现相关。作者介绍了来自其自身临床实践的两名患者,他们接受α干扰素治疗后出现了并发症,作者认为这些并发症可能与自身免疫有关(一名血小板减少症患者对免疫抑制治疗反应良好,最初因肾癌接受治疗,以及一名患有肺结节病的女性患者因原发性血小板增多症接受治疗)。作者还简要回顾了关于干扰素诱发自身免疫的文献。